Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 6:41 pm Purchase |
2024-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 10,713,627 7.600% |
2,721,396 (+34.05%) |
Filing History |
| 2024-11-14 1:13 pm Sale |
2024-09-30 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 7,992,231 5.700% |
-3,645,288 (-31.32%) |
Filing History |
| 2024-02-14 09:54 am Purchase |
2023-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 11,637,519 10.400% |
10,317 (+0.09%) |
Filing History |
| 2023-02-14 10:45 am Purchase |
2022-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 11,627,202 10.800% |
1,209,639 (+11.61%) |
Filing History |
| 2022-02-10 4:44 pm Sale |
2021-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 10,417,563 11.600% |
-503,008 (-4.61%) |
Filing History |
| 2021-02-12 6:02 pm Purchase |
2020-12-31 | 13G | Silence Therapeutics plc SLN |
Lombard Odier Asset Management (USA) Corp | 10,920,571 12.200% |
10,920,571 (New Position) |
Filing History |